Velocity Pharmaceutical Holdings Llc - Net Worth and Insider Trading
Velocity Pharmaceutical Holdings Llc Net Worth
The estimated net worth of Velocity Pharmaceutical Holdings Llc is at least $12 Million dollars as of 2024-04-27. Velocity Pharmaceutical Holdings Llc is the 10% Owner of Altimmune Inc and owns about 1,687,250 shares of Altimmune Inc (ALT) stock worth over $12 Million. Details can be seen in Velocity Pharmaceutical Holdings Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Velocity Pharmaceutical Holdings Llc has not made any transactions after 2020-05-15 and currently still holds the listed stock(s).
Transaction Summary of Velocity Pharmaceutical Holdings Llc
Velocity Pharmaceutical Holdings Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Velocity Pharmaceutical Holdings Llc owns 1 companies in total, including Altimmune Inc (ALT) .
Insider Ownership Summary of Velocity Pharmaceutical Holdings Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALT | Altimmune Inc | 2020-05-15 | 10 percent owner |
Velocity Pharmaceutical Holdings Llc Latest Holdings Summary
Velocity Pharmaceutical Holdings Llc currently owns a total of 1 stock. Velocity Pharmaceutical Holdings Llc owns 1,687,250 shares of Altimmune Inc (ALT) as of May 15, 2020, with a value of $12 Million.
Latest Holdings of Velocity Pharmaceutical Holdings Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALT | Altimmune Inc | 2020-05-15 | 1,687,250 | 7.26 | 12,249,435 |
Holding Weightings of Velocity Pharmaceutical Holdings Llc
Velocity Pharmaceutical Holdings Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Velocity Pharmaceutical Holdings Llc has made a total of 1 transactions in Altimmune Inc (ALT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Altimmune Inc is the sale of 200,000 shares on May 15, 2020, which brought Velocity Pharmaceutical Holdings Llc around $958,000.
Insider Trading History of Velocity Pharmaceutical Holdings Llc
- 1
Velocity Pharmaceutical Holdings Llc Trading Performance
Velocity Pharmaceutical Holdings Llc Ownership Network
Ownership Network List of Velocity Pharmaceutical Holdings Llc
Ownership Network Relation of Velocity Pharmaceutical Holdings Llc
Velocity Pharmaceutical Holdings Llc Owned Company Details
What does Altimmune Inc do?
Who are the key executives at Altimmune Inc?
Velocity Pharmaceutical Holdings Llc is the 10 percent owner of Altimmune Inc. Other key executives at Altimmune Inc include Chief Financial Officer Richard I Eisenstadt , Chief Medical Officer Matthew Scott Harris , and Chief Business Officer Raymond M Jordt .
Altimmune Inc (ALT) Insider Trades Summary
Over the past 18 months, Velocity Pharmaceutical Holdings Llc made no insider transaction in Altimmune Inc (ALT). Other recent insider transactions involving Altimmune Inc (ALT) include a net purchase of 9,300 shares made by David Drutz , a net sale of 20,000 shares made by Wayne Pisano , and a net purchase of 10,000 shares made by Richard I Eisenstadt .
In summary, during the past 3 months, insiders sold 0 shares of Altimmune Inc (ALT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 20,000 shares of Altimmune Inc (ALT) were sold and 29,300 shares were bought by its insiders, resulting in a net purchase of 9,300 shares.
Altimmune Inc (ALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Altimmune Inc Insider Transactions
Velocity Pharmaceutical Holdings Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Velocity Pharmaceutical Holdings Llc. You might contact Velocity Pharmaceutical Holdings Llc via mailing address: 400 Oyster Blvd., Suite 202, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
